Statins for allBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1899 (Published 03 March 2014) Cite this as: BMJ 2014;348:g1899
- Des Spence, general practitioner, Glasgow
The UK National Institute for Health and Care Excellence has issued new guidelines on lipid lowering. The headlines are: lower the treatment threshold for primary prevention to people with a 10 year risk of 10%, use atorvastatin preferentially, and use the Qrisk assessment tool.1 This guidance, authored by a small group of important cholesterol specialists, is surely a scientific and thought through analysis of the research data. Shouldn’t we embrace such authoritative advice?
The guidelines rely on a simplistic model of the cause of ischaemic heart disease, assuming that its decline is merely the result of a reduction …
Log in using your username and password
Log in through your institution
Sign up for a free trial